Zephrex-D, a product of Westport Pharmaceuticals, recently went on sale in Oklahoma. The Missouri Narcotics Officers Association reportedly tested Zephrex-D to see if could be used to make meth using the “shake-and-bake” process. Couldn't be done.
The product is competitively priced. Time will tell if consumers find it as effective as other pseudoephedrine products. Still, it's encouraging that the market is responding to demand for effective allergy medicines that can't be used for meth production.
Paul Hemings, a Westport vice president, said Zephrex-D is meant “to end meth labs across America” without inconveniencing consumers. Oklahoma lawmakers should have the same goal when debating future anti-meth legislation.